Perspective Therapeutics (CATX) Asset Utilization Ratio (2011 - 2023)
Perspective Therapeutics (CATX) posted Asset Utilization Ratio of 0.01 for Q4 2023, down 92.73% sequentially from 0.11 in Q3 2023.
Perspective Therapeutics (CATX) Asset Utilization Ratio (2011 - 2023) Analysis & Trends
Perspective Therapeutics has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.01 in Q4 2023.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.01 (changed N/A YoY) and the FY2023 annual result came in at 0.02, changed N/A from the prior year.
- Asset Utilization Ratio fell to 0.01 in Q4 2023 per CATX's latest filing, from 0.11 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 1.17 in Q3 2020 and troughed at 0.01 in Q4 2023.
- A 5-year average of 0.47 and a median of 0.22 in 2021 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio plunged 87.38% in 2021, then surged 95.65% in 2022.
- Over 5 years, Asset Utilization Ratio stood at 0.88 in 2019, then decreased by 4.21% to 0.84 in 2020, then sank by 81.31% to 0.16 in 2021, then jumped by 83.03% to 0.29 in 2022, then slumped by 97.18% to 0.01 in 2023.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.11, and 0.13 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.56 |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.19 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.16 |
| Sep 30, 2021 | 0.15 |
| Jun 30, 2021 | 0.14 |
| Mar 31, 2021 | 0.22 |
| Dec 31, 2020 | 0.84 |
| Sep 30, 2020 | 1.17 |
| Jun 30, 2020 | 1.10 |
| Mar 31, 2020 | 1.04 |
| Dec 31, 2019 | 0.88 |
| Sep 30, 2019 | 0.83 |
| Jun 30, 2019 | 0.73 |
| Mar 31, 2019 | 0.62 |
| Dec 31, 2018 | 0.53 |